390 related articles for article (PubMed ID: 16255854)
1. [Expression of connective tissue growth factor in progressive muscular dystrophy].
Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy.
Sun G; Haginoya K; Wu Y; Chiba Y; Nakanishi T; Onuma A; Sato Y; Takigawa M; Iinuma K; Tsuchiya S
J Neurol Sci; 2008 Apr; 267(1-2):48-56. PubMed ID: 17996907
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
[TBL] [Abstract][Full Text] [Related]
5. Expression of tissue inhibitor of metalloproteinase-1 in progression muscular dystrophy.
Sun GL; Zhao S; Li P; Jiang HK
Neurosci Bull; 2006 Mar; 22(2):85-90. PubMed ID: 17687403
[TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
[TBL] [Abstract][Full Text] [Related]
8. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy.
Morales MG; Cabello-Verrugio C; Santander C; Cabrera D; Goldschmeding R; Brandan E
J Pathol; 2011 Dec; 225(4):490-501. PubMed ID: 21826667
[TBL] [Abstract][Full Text] [Related]
9. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
Wang S; Shen D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
[TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.
Bernasconi P; Torchiana E; Confalonieri P; Brugnoni R; Barresi R; Mora M; Cornelio F; Morandi L; Mantegazza R
J Clin Invest; 1995 Aug; 96(2):1137-44. PubMed ID: 7635950
[TBL] [Abstract][Full Text] [Related]
11. Muscle histochemistry in congenital muscular dystrophy with central nervous system involvement.
Nonaka I; Sugita H; Takada K; Kumagai K
Muscle Nerve; 1982 Feb; 5(2):102-6. PubMed ID: 6461828
[TBL] [Abstract][Full Text] [Related]
12. Abnormal localization of laminin subunits in muscular dystrophies.
Hayashi YK; Engvall E; Arikawa-Hirasawa E; Goto K; Koga R; Nonaka I; Sugita H; Arahata K
J Neurol Sci; 1993 Oct; 119(1):53-64. PubMed ID: 8246011
[TBL] [Abstract][Full Text] [Related]
13. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical analysis of dystrophin in congenital muscular dystrophy.
Arikawa E; Ishihara T; Nonaka I; Sugita H; Arahata K
J Neurol Sci; 1991 Sep; 105(1):79-87. PubMed ID: 1795174
[TBL] [Abstract][Full Text] [Related]
15. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
[TBL] [Abstract][Full Text] [Related]
16. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.
Miike T
Muscle Nerve; 1983 Oct; 6(8):545-52. PubMed ID: 6196637
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C
Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
[TBL] [Abstract][Full Text] [Related]
18. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
20. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
